0
0
0
Affordable Drug Manufacturing Act of 2020
2/8/2022, 11:22 PM
Congressional Summary of S 3162
Affordable Drug Manufacturing Act of 2020
This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
Read the Full Bill
Current Status of Bill S 3162
Bill S 3162 is currently in the status of Bill Introduced since January 8, 2020. Bill S 3162 was introduced during Congress 116 and was introduced to the Senate on January 8, 2020. Bill S 3162's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 8, 2020
Bipartisan Support of Bill S 3162
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3162
Primary Policy Focus
HealthPotential Impact Areas
- Competition and antitrust
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Executive agency funding and structure
- Federal officials
- Government employee pay, benefits, personnel management
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health programs administration and funding
- Inflation and prices
- Licensing and registrations
- Manufacturing
- Prescription drugs
- Public contracts and procurement
- Public participation and lobbying
Alternate Title(s) of Bill S 3162
Affordable Drug Manufacturing Act of 2020
Affordable Drug Manufacturing Act of 2020
A bill to amend the Public Health Service Act to establish an Office of Drug Manufacturing.
Comments
Sponsors and Cosponsors of S 3162
Latest Bills
Strengthening America’s Turning Point Act
Bill S 1518July 26, 2026
Unlocking Native Lands and Opportunities for Commerce and Key Economic Developments Act of 2025
Bill S 3383July 25, 2026
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Bill HR 3029July 25, 2026
Transparency in Billing Act of 2026
Bill HR 8684July 25, 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Bill S 4472July 25, 2026
Connected Vehicle Security Act of 2026
Bill S 4429July 25, 2026
Protecting American Taxpayers Act
Bill S 4952July 25, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784July 25, 2026
Renewing the African American Civil Rights Network Act
Bill S 4767July 25, 2026
National Plan for Epilepsy Act
Bill S 494July 25, 2026
Affordable Drug Manufacturing Act of 2019
Bill HR 5501October 28, 2022